$0 is the total value of Ridgeback Capital Investments L.P.'s 1 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FSTX | Exit | F-STAR THERAPEUTICS INC. | $0 | – | -1,834,360 | -100.0% | -5.02% | – |
| AFMD | Exit | AFFIMED NV | $0 | – | -7,722,106 | -100.0% | -23.22% | – |
| BCYC | Exit | BICYCLE THERAPEUTICS INC.ads | $0 | – | -2,164,801 | -100.0% | -71.77% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| 0 | 29 | Q3 2023 | 0.0% |
| 0 | 8 | Q2 2015 | 0.0% |
| BICYCLE THERAPEUTICS INC. | 2 | Q4 2022 | 80.4% |
| APPLIED GENETIC TECHNOLOGIES INC. | 2 | Q4 2015 | 100.0% |
| CELLDEX THERAPEUTICS INC | 2 | Q4 2013 | 74.6% |
| AFFIMED NV | 2 | Q4 2022 | 23.2% |
| F-STAR THERAPEUTICS INC. | 2 | Q4 2022 | 5.0% |
| KARYOPHARM THERAPEUTICS INC. | 1 | Q4 2018 | 100.0% |
| SANGAMO BIOSCIENCES INC | 1 | Q4 2013 | 50.9% |
| CARA THERAPEUTICS, INC. | 1 | Q4 2015 | 45.1% |
View Ridgeback Capital Investments L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| F-star Therapeutics, Inc. | February 14, 2023 | 52,509 | 0.2% |
| Cogent Biosciences, Inc. | February 14, 2022 | ? | ? |
| 4D Molecular Therapeutics Inc. | February 16, 2021 | 1,100,000 | 4.2% |
| MYOMO, INC. | February 16, 2021 | 104,755 | 2.3% |
| SUTRO BIOPHARMA, INC. | February 16, 2021 | 1,144,979 | 2.5% |
| Verastem, Inc. | February 16, 2021 | ? | ? |
| Unum Therapeutics Inc. | July 16, 2020 | 2,400,000 | 6.2% |
| Karyopharm Therapeutics Inc. | February 14, 2020 | ? | ? |
| Spring Bank Pharmaceuticals, Inc. | January 06, 2020 | 1,142,900 | 6.9% |
| Corium International, Inc. | March 15, 2018 | 1,914,265 | 5.2% |
View Ridgeback Capital Investments L.P.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-01-26 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
View Ridgeback Capital Investments L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.